Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,315,000 | 12,851,000 | 13,965,000 | 7,417,000 | 10,635,000 |
| Marketable Securities | 2,004,000 | 1,756,000 | 1,749,000 | 1,194,000 | 659,000 |
| Receivables | 6,163,000 | 5,854,000 | 6,105,000 | 5,331,000 | 4,835,000 |
| Inventories | 1,880,000 | 1,955,000 | 1,988,000 | 2,039,000 | 1,908,000 |
| Income taxes - deferred | 830,000 | 828,000 | 894,000 | 833,000 | 655,000 |
| Other current assets | 0 | 0 | 0 | 553,000 | 761,000 |
| TOTAL | $19,267,000 | $24,762,000 | $25,910,000 | $18,093,000 | $20,062,000 |
| Non-Current Assets | |||||
| PPE Net | 2,431,000 | 2,276,000 | 2,143,000 | 1,899,000 | 1,765,000 |
| Investments And Advances | 13,003,000 | 11,601,000 | 9,400,000 | 6,056,000 | 3,220,000 |
| Intangibles | 11,095,000 | 11,419,000 | 11,626,000 | 11,832,000 | 12,039,000 |
| Other Non-Current Assets | 1,969,000 | 1,658,000 | 1,558,000 | 1,287,000 | 1,235,000 |
| TOTAL | $28,498,000 | $26,954,000 | $24,727,000 | $21,074,000 | $18,259,000 |
| Total Assets | $47,765,000 | $51,716,000 | $50,637,000 | $39,167,000 | $38,321,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,745,000 | 982,000 | 331,000 | 352,000 | 442,000 |
| Accounts payable and accrued liabilities | 945,000 | 1,178,000 | 1,239,000 | 1,571,000 | 1,011,000 |
| Accrued Expenses | 4,766,000 | 4,118,000 | 4,713,000 | 4,635,000 | 4,246,000 |
| TOTAL | $10,910,000 | $9,890,000 | $9,360,000 | $8,925,000 | $7,428,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 21,451,000 | 21,468,000 | 22,272,000 | 12,682,000 | 12,540,000 |
| Deferred Revenues | 529,000 | 440,000 | 356,000 | 501,000 | 191,000 |
| Other Non-Current Liabilities | 1,384,000 | 1,243,000 | 1,039,000 | 885,000 | 725,000 |
| TOTAL | $22,836,000 | $22,713,000 | $23,333,000 | $13,608,000 | $13,305,000 |
| Total Liabilities | $33,746,000 | $32,603,000 | $32,693,000 | $22,533,000 | $20,733,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,331,822 | 1,366,846 | 1,441,180 | 1,467,606 | 1,469,606 |
| Common Shares | 1,000 | 1,000 | 1,000 | 2,000 | 1,000 |
| Retained earnings | 13,045,000 | 18,001,000 | 16,961,000 | 16,038,000 | 13,916,000 |
| Other shareholders' equity | 457,000 | 667,000 | 697,000 | 594,000 | 947,000 |
| TOTAL | $14,019,000 | $19,113,000 | $17,944,000 | $16,634,000 | $17,588,000 |
| Total Liabilities And Equity | $47,765,000 | $51,716,000 | $50,637,000 | $39,167,000 | $38,321,000 |